GlassScriptPhysician profile
Anthony P Lebario
NPI 1326205808
$86,950.24
in general payments reported to CMS, 2019-2025
15 companies · $3,452 in 2025
The $3,452 reported for 2025 was more than what 92% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43K · 2021: $27K · 2022: $9,548 · 2023: $1,548 · 2024: $2,056 · 2025: $3,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,502 · Food and Beverage: $2,442 · Travel and Lodging: $2,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,501.67 |
| Food and Beverage | $2,442.36 |
| Travel and Lodging | $2,112.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $80,435.79 | 2020-2023 | Gilenya |
| Pacira Pharmaceuticals Incorporated | $4,077.28 | 2023-2025 | Iovera, Zilretta |
| Boston Scientific Corporation | $1,403.55 | 2022-2025 | General - Pain Management, General - Therapies |
| Averitas Pharma INC. | $343.39 | 2023-2025 | Qutenza |
| Biotronik Nro, INC. | $197.71 | 2023-2024 | Prospera, Biotronik |
| Medtronic, INC. | $174.77 | 2022-2023 | Intellis Adaptivestim |
| Abbott Laboratories | $94.45 | 2022 | |
| Spr Therapeutics, INC | $53.57 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $37.05 | 2022 | |
| Abbvie INC. | $33.87 | 2024 | |
| Bioventus LLC | $27.06 | 2024 | Stimrouter Implantable Kit |
| Si-Bone, INC. | $22.78 | 2023 | |
| Foundation Fusion Solutions, LLC | $20.60 | 2021-2022 | |
| Relievant Medsystems, INC. | $15.04 | 2023 | Intracept |
| Novus Surgical Consultants | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lebario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.